Contract Pharma: AbSci Acquires Cell Therapy Company Totient | Absci Contract Pharma: AbSci Acquires Cell Therapy Company Totient - Absci

06.17.2021

Contract Pharma: AbSci Acquires Cell Therapy Company Totient

Totient, a biotech company harnessing human immune responses to identify novel antibodies and their therapeutic targets, has been acquired by Absci. Read more.